Reklama
WIG82 745,58+1,45%
WIG202 436,05+1,72%
EUR / PLN4,31-0,12%
USD / PLN4,00+0,10%
CHF / PLN4,43+0,41%
GBP / PLN5,04+0,08%
EUR / USD1,08-0,22%
DAX18 492,49+0,08%
FT-SE7 952,62+0,26%
CAC 408 205,81+0,01%
DJI39 807,37+0,12%
S&P 5005 254,35+0,11%
ROPA BRENT86,86+1,35%
ROPA WTI83,03+1,60%
ZŁOTO2 232,81+1,87%
SREBRO24,98+1,67%

Masz ciekawy temat? Napisz do nas

twitter
youtube
facebook
instagram
linkedin
Reklama
Reklama

SOPHARMA AD komunikaty espi ebi

POLISH FINANCIAL SUPERVISION AUTHORITY

UNI - EN REPORT No8/2021
Date of issue:2021-03-15
Short name of the issuer
SOPHARMA AD
Subject
Common policy agreement for the management of “Momina krepost” AD
Official market - legal basis
art. 56. 1. 2 of Act on Public Offering.
Unofficial market - legal basis
Contents of the report:
Sopharma AD notifies that on its meeting, the Board of Directors of the Company decided to enter into a common policy agreement for the management of “Momina Krepost” AD with “Medical Supplies” OOD holding 56.59% of the votes in the General Meeting of “Momina Krepost” AD through joint exercise of voting rights.
The parties will coordinate their actions on all significant issues concerning the company's activities, such as transformation or termination of the company, changes in the amount of the company's capital, amendments or supplements to the Articles of Association, changes in the composition of management bodies, staff and conditions. on employment contracts, the main activity and the financial strategy of the company, etc.
Annexes
FileDescription
SFA_MOMKR_Agreement_15032021_espi.pdfCommon policy agreement for the management of “Momina krepost” AD
SOPHARMA AD
(fullname of the issuer)
SOPHARMA ADFarmaceutyczny (far)
(short name of the issuer)(sector according to clasification
of the WSE in Warsow)
1220Sofia
(post code)(city)
IlienskoShosse16
(street)(number)
+359 2 813 42 00+359 2 936 02 86
(phone number)(fax)
(e-mail)(web site)
nd
(NIP)(REGON)

SIGNATURE OF PERSONS REPRESENTING THE COMPANY
DateNamePosition / FunctionSignature
2021-03-15Ognian DonevExecutive Director
Czytaj więcej